{"id":"emedastine","rwe":[{"pmid":"30000584","year":"2006","title":"Emedastine.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"38417904","year":"2024","title":"Emedastine Inhibits Th1 and Th2 Cell Differentiation Mediated by Mast Cells.","finding":"","journal":"Biological & pharmaceutical bulletin","studyType":"Clinical Study"},{"pmid":"37088368","year":"2023","title":"Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.","finding":"","journal":"The journal of allergy and clinical immunology. In practice","studyType":"Clinical Study"},{"pmid":"36719625","year":"2023","title":"Identification of lncRNA-miRNA-mRNA Regulatory Network and Therapeutic Agents for Skin Aging by Bioinformatics Analysis.","finding":"","journal":"Biochemical genetics","studyType":"Clinical Study"},{"pmid":"36257488","year":"2022","title":"Protective effect of biogenic selenium nanoparticles against diquat-induced acute toxicity via regulation of gut microbiota and its metabolites.","finding":"","journal":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","studyType":"Clinical Study"}],"tags":[{"label":"Histamine-1 Receptor Inhibitor","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"S01GX06","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Allergic conjunctivitis","category":"indication"},{"label":"Itching of skin","category":"indication"},{"label":"Urticaria","category":"indication"},{"label":"Novartis","category":"company"},{"label":"Approved 1990s","category":"decade"},{"label":"Anti-Allergic Agents","category":"pharmacology"},{"label":"Histamine Agents","category":"pharmacology"},{"label":"Histamine Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Novartis","patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:55:17.166482","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=EMEDASTINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:35:40.743730+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:35:52.430213+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EMEDASTINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:35:53.377180+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Histamine H1 receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:35:53.947509+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103739/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:35:53.842019+00:00"}},"allNames":"emadine","offLabel":[],"synonyms":["emedastine difumarate ophthalmic solution","emedastine fumarate","emadine","emedastine","emedastine difumarate","daren"],"timeline":[{"date":"1997-01-01","type":"neutral","source":"FDA Orange Book","milestone":"Rights transferred from ALCON to Novartis"},{"date":"1997-12-29","type":"positive","source":"DrugCentral","milestone":"FDA approval (Alcon)"}],"aiSummary":"Emadine (Emedastine) is a small molecule histamine-1 receptor inhibitor originally developed by Alcon and currently owned by Novartis. It was FDA-approved in 1997 for the treatment of allergic conjunctivitis, itching of the skin, and urticaria. Emadine works by blocking the histamine H1 receptor, which is involved in the allergic response. It is off-patent and has no active generic manufacturers. Key safety considerations include its potential to cause eye irritation and dryness.","approvals":[{"date":"1997-12-29","orphan":false,"company":"ALCON","regulator":"FDA"}],"brandName":"Emadine","ecosystem":[{"indication":"Allergic conjunctivitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alcaftadine","slug":"alcaftadine","company":"Allergan"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Itching of skin","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"allantoin","slug":"allantoin","company":""},{"name":"ammonium lactate","slug":"ammonium-lactate","company":"Ranbaxy"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Urticaria","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""},{"name":"brompheniramine","slug":"brompheniramine","company":""}],"globalPrevalence":68000000}],"mechanism":{"target":"Histamine H1 receptor","novelty":"Follow-on","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor","isPrimary":true,"activityType":"Ki","activityValue":8.886}],"moaClass":"Histamine H1 Receptor Antagonists","modality":"Small Molecule","drugClass":"Histamine-1 Receptor Inhibitor","explanation":"","oneSentence":"","technicalDetail":"Emadine is a competitive antagonist of the histamine H1 receptor, with a bioavailability of 50% and an unknown half-life. It is a small molecule that binds to the H1 receptor, preventing histamine from binding and triggering an allergic response."},"commercial":{"launchDate":"1997","_launchSource":"DrugCentral (FDA 1997-12-29, ALCON)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/999","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=EMEDASTINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EMEDASTINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T10:54:59.980991","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:36:06.836729+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cromoglicic acid","drugSlug":"cromoglicic-acid","fdaApproval":"1982-05-28","relationship":"same-class"},{"drugName":"levocabastine","drugSlug":"levocabastine","fdaApproval":"1993-11-10","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"nedocromil","drugSlug":"nedocromil","fdaApproval":"1992-12-30","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"lodoxamide","drugSlug":"lodoxamide","fdaApproval":"1993-09-23","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"azelastine","drugSlug":"azelastine","fdaApproval":"1996-11-01","patentExpiry":"Jun 4, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ketotifen","drugSlug":"ketotifen","fdaApproval":"1999-07-02","patentExpiry":"Mar 27, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"olopatadine","drugSlug":"olopatadine","fdaApproval":"1996-12-18","patentExpiry":"May 19, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"epinastine","drugSlug":"epinastine","fdaApproval":"2003-10-16","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"alcaftadine","drugSlug":"alcaftadine","fdaApproval":"2010-07-28","patentExpiry":"Mar 19, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"cetirizine","drugSlug":"cetirizine","fdaApproval":"1995-12-08","patentExpiry":"Sep 15, 2030","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"emedastine","indications":{"approved":[{"name":"Allergic conjunctivitis","source":"DrugCentral","snomedId":473460002,"regulator":"FDA"},{"name":"Itching of skin","source":"DrugCentral","snomedId":418363000,"regulator":"FDA"},{"name":"Urticaria","source":"DrugCentral","snomedId":126485001,"regulator":"FDA","usPrevalence":null,"globalPrevalence":68000000,"prevalenceMethod":"curated","prevalenceSource":"Allergy, 2020 (PMID:31494963)"}],"offLabel":[],"pipeline":[]},"_fixedFields":["primaryTarget"],"currentOwner":"Novartis","drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"cromoglicic-acid","brandName":"cromoglicic acid","genericName":"cromoglicic acid","approvalYear":"1982","relationship":"same-class"},{"drugId":"levocabastine","brandName":"levocabastine","genericName":"levocabastine","approvalYear":"1993","relationship":"same-class"},{"drugId":"nedocromil","brandName":"nedocromil","genericName":"nedocromil","approvalYear":"1992","relationship":"same-class"},{"drugId":"lodoxamide","brandName":"lodoxamide","genericName":"lodoxamide","approvalYear":"1993","relationship":"same-class"},{"drugId":"azelastine","brandName":"azelastine","genericName":"azelastine","approvalYear":"1996","relationship":"same-class"},{"drugId":"ketotifen","brandName":"ketotifen","genericName":"ketotifen","approvalYear":"1999","relationship":"same-class"},{"drugId":"olopatadine","brandName":"olopatadine","genericName":"olopatadine","approvalYear":"1996","relationship":"same-class"},{"drugId":"epinastine","brandName":"epinastine","genericName":"epinastine","approvalYear":"2003","relationship":"same-class"},{"drugId":"alcaftadine","brandName":"alcaftadine","genericName":"alcaftadine","approvalYear":"2010","relationship":"same-class"},{"drugId":"cetirizine","brandName":"cetirizine","genericName":"cetirizine","approvalYear":"1995","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05318157","phase":"PHASE4","title":"Efficacy of Artemisia Pollen Specific Allergen Immunotherapy","status":"UNKNOWN","sponsor":"Beijing Tongren Hospital","startDate":"2022-03-31","conditions":["Allergic Rhinitis"],"enrollment":150,"completionDate":"2024-11-30"},{"nctId":"NCT00133627","phase":"PHASE4","title":"Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-04","conditions":["Seasonal Allergic Conjunctivitis"],"enrollment":229,"completionDate":"2005-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"MMSL":"11537","NDDF":"007385","UNII":"9J1H7Y9OJV","CHEBI":"CHEBI:4779","VANDF":"4021082","INN_ID":"6257","RXNORM":"216882","UMLSCUI":"C0064263","chemblId":"CHEMBL2103739","ChEMBL_ID":"CHEMBL594","KEGG_DRUG":"D02249","DRUGBANK_ID":"DB01084","PUBCHEM_CID":"3219","SNOMEDCT_US":"108846000","IUPHAR_LIGAND_ID":"7174","SECONDARY_CAS_RN":"87233-62-3","MESH_SUPPLEMENTAL_RECORD_UI":"C043345"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1997-","companyName":"Alcon","relationship":"Original Developer"},{"period":"present","companyName":"Novartis","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"50%"},"publicationCount":80,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"S01GX06","allCodes":["S01GX06"]},"biosimilarFilings":[],"originalDeveloper":"Alcon","recentPublications":[{"date":"2006","pmid":"30000584","title":"Emedastine.","journal":""},{"date":"2024","pmid":"38417904","title":"Emedastine Inhibits Th1 and Th2 Cell Differentiation Mediated by Mast Cells.","journal":"Biological & pharmaceutical bulletin"},{"date":"2023 Aug","pmid":"37088368","title":"Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.","journal":"The journal of allergy and clinical immunology. In practice"},{"date":"2023 Aug","pmid":"36719625","title":"Identification of lncRNA-miRNA-mRNA Regulatory Network and Therapeutic Agents for Skin Aging by Bioinformatics Analysis.","journal":"Biochemical genetics"},{"date":"2022 Dec","pmid":"36257488","title":"Protective effect of biogenic selenium nanoparticles against diquat-induced acute toxicity via regulation of gut microbiota and its metabolites.","journal":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"Novartis","companyId":"novartis","modality":"Small molecule","firstApprovalDate":"1997","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1997-12-29T00:00:00.000Z","mah":"ALCON","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1997-12-29T00:00:00.000Z","mah":"ALCON","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1997-12-29T00:00:00.000Z","mah":"ALCON","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1997-12-29T00:00:00.000Z","mah":"ALCON","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1997-12-29T00:00:00.000Z","mah":"ALCON","brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1997-12-29T00:00:00.000Z","mah":"ALCON","brand_name_local":null,"application_number":""},{"country_code":"NZ","regulator":"Medsafe","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"AT","regulator":"AGES","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"BE","regulator":"FAMHP","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"EU","regulator":"EMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":"EMEA/H/C/000223"},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"BG","regulator":"BDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"HR","regulator":"HALMED","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"CY","regulator":"PHS","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"CZ","regulator":"SUKL","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"DK","regulator":"DKMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"EE","regulator":"SAM","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"FI","regulator":"Fimea","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"FR","regulator":"ANSM","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"DE","regulator":"BfArM","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"GR","regulator":"EOF","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"HU","regulator":"OGYEI","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"IE","regulator":"HPRA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"IT","regulator":"AIFA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"LV","regulator":"ZVA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"LT","regulator":"VVKT","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"LU","regulator":"MS","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"MT","regulator":"MMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"NL","regulator":"MEB","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"PL","regulator":"URPL","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"PT","regulator":"Infarmed","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"RO","regulator":"ANMDMR","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"SK","regulator":"SIDC","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"SI","regulator":"JAZMP","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"ES","regulator":"AEMPS","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"SE","regulator":"MPA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"AU","regulator":"TGA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"CH","regulator":"Swissmedic","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"NO","regulator":"NoMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null},{"country_code":"IS","regulator":"IMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Emadine","application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:36:06.836729+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}